Novo Nordisk shares drop more than 4% on disappointing obesity pill data
- Posted on September 20, 2024
- By Business News Today
- 1 Views
Novo Nordisk shares drop more than 4% on disappointing obesity pill data
Shares were down 4.3% at 1330 GMT, the lowest since August 8, after the company announced headline results from its trial of monlunabant, an experimental drug it acquired as part of its $1 billion purchase of Canadian biotech company Inversago Pharmaceuticals last year.
